Author:
Asal Fathia Elsayed,Yousef Mohamed,Abdraboh Hend Atteya Abdelkhalek,Abd-Elsalam Sherief,Abdelaziz Shama Ahmed Abdelaziz,Elbahnasawy Mohamed,Elnaggar Mohammed H,Alsrogy Hesham Ahmed,Elashry Heba
Abstract
Background:
Assessment of cystatin C levels could be valuable in the early detection of renal dysfunction because they increase faster than the creatinine levels as the GFR decreases. The aim of this work was to evaluate serum cystatin C as a diagnostic tool for renal dysfunction in cirrhotic patients with and without hepatorenal syndrome (HRS).
Methods:
This case-control study was conducted on 60 patients from the Tropical Medicine Department of Tanta University Hospitals and 10 people served as healthy control volunteers. Serum cystatin C was measured in the three groups.
Results:
A significant difference was observed among the three groups as cystatin C was higher in patients with HRS compared to the cirrhotic group and healthy controls.
Conclusion:
Serum cystatin C is a good predictor for hepatorenal syndrome with a good correlation with serum creatinine, blood urea, GFR, and creatinine clearance.
Publisher
Bentham Science Publishers Ltd.
Subject
Biochemistry (medical),Clinical Biochemistry,Medicine (miscellaneous)
Reference35 articles.
1. Friedman LS, Martin P.
Handbook of Liver Disease E-Book
2017.
2. Ginès P, Guevara M, Arroyo V, Rodés J.
Hepatorenal syndrome.
Lancet
2003;
362
(9398)
: 1819-27.
3. Ng CKF, Chan MH, Tai MH, Lam CW.
Hepatorenal syndrome.
Clin Biochem Rev
2007;
28
(1)
: 11-7.
4. Ginès P, Schrier RW.
Renal failure in cirrhosis.
N Engl J Med
2009;
361
(13)
: 1279-90.
5. Garcia-Tsao G, Parikh CR, Viola A.
Acute kidney injury in cirrhosis.
Hepatology
2008;
48
(6)
: 2064-77.